ES427232A1 - A procedure to remove and insulate the enzymatic component from the venom of the serpents. (Machine-translation by Google Translate, not legally binding) - Google Patents

A procedure to remove and insulate the enzymatic component from the venom of the serpents. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES427232A1
ES427232A1 ES427232A ES427232A ES427232A1 ES 427232 A1 ES427232 A1 ES 427232A1 ES 427232 A ES427232 A ES 427232A ES 427232 A ES427232 A ES 427232A ES 427232 A1 ES427232 A1 ES 427232A1
Authority
ES
Spain
Prior art keywords
venom
elution
eluate
vitro
translation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES427232A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratori Biochimici Fargal Pharmasiast SpA
Original Assignee
Laboratori Biochimici Fargal Pharmasiast SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratori Biochimici Fargal Pharmasiast SpA filed Critical Laboratori Biochimici Fargal Pharmasiast SpA
Publication of ES427232A1 publication Critical patent/ES427232A1/en
Expired legal-status Critical Current

Links

Landscapes

  • Extraction Or Liquid Replacement (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A method for extracting and isolating snake venom from the enzymatic component having "in vitro" coagulant activity and "in vivo" anticoagulant activity from the other components having "in vitro" coagulant activity and from the protein components, whose process is characterized because the venom of the snakes, dissolved in a suitable medium for a chromatographic separation treatment, is passed through a column filled with a solid support for the selective absorption of said anticoagulant enzyme "in vivo", not soluble in aqueous solvents and combined to a substrate or inhibitor of said enzyme, a first elution medium is passed to ph 6-7 and a molarity less than or equal to 0.05% through said filling into which the poison has been introduced, is collected the eluate in successive portions until the elution of more than 95% of the protein components of the venom and the coagulant fraction "in vitro" has been obtained, different from the in the second eluate, a second elution medium is passed to a ph even higher than 9 and a molarity greater than or equal to 0.3m, and the eluate is collected in successive portions until elution of the anticoagulant enzyme is obtained. Live "absorbed in the column, along with less than 5% of the protein components. (Machine-translation by Google Translate, not legally binding)
ES427232A 1973-09-03 1974-06-12 A procedure to remove and insulate the enzymatic component from the venom of the serpents. (Machine-translation by Google Translate, not legally binding) Expired ES427232A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT4240973 1973-09-03

Publications (1)

Publication Number Publication Date
ES427232A1 true ES427232A1 (en) 1976-09-01

Family

ID=11253965

Family Applications (1)

Application Number Title Priority Date Filing Date
ES427232A Expired ES427232A1 (en) 1973-09-03 1974-06-12 A procedure to remove and insulate the enzymatic component from the venom of the serpents. (Machine-translation by Google Translate, not legally binding)

Country Status (1)

Country Link
ES (1) ES427232A1 (en)

Similar Documents

Publication Publication Date Title
ES8501413A1 (en) PROCEDURE TO PREPARE A SAFE MEDICATION AGAINST HEPATITIS CONTAINING PROTEIN CALLED INACTIVATOR CL.
SE8204400D0 (en) METHOD OF PROCEDURE FOR POROSA CELLULOSAPERLOR
US3743722A (en) Anti-coagulant isolation
Klucis et al. Sequential alterations in the micro-localization of catalase in mouse liver after treatment with hypolipidemic drugs
EP0216936A4 (en) Novel tannin composition.
ES447851A1 (en) Process for the extraction of components having anticoagulant activity {37 in vivo{38 {0 from snake venoms and products obtained
KR850003166A (en) Method for Purifying Hepatitis B Virus Surface Antigen (HBs Antigen)
DE2363201B2 (en) Process for the isolation and purification of kallikrein from biological material
GB908333A (en) Method for the production of substantially protein-free callicrein
DE59000141D1 (en) METHOD FOR ISOLATING THE BLOOD COagulation FACTOR IX.
ES427232A1 (en) A procedure to remove and insulate the enzymatic component from the venom of the serpents. (Machine-translation by Google Translate, not legally binding)
Plaut et al. [119] Diphosphopyridine nucleotide isocitric dehydrogenase from animal tissues: d-Isocitric acid+ DPN+→ α-Ketoglutaric acid+ CO2+ DPN· H+ H+
SE7905611L (en) PROCEDURE AND ADSORPTION FOR INSULATION AND PENECOMMISSION OF ENZYMES FROM A RAENZYME SOLUTION
Seibert et al. The conservation of poly-A-containing RNA during the dormant state of the moss Polytrichum commune
US4205130A (en) Method of purification of human prostatic acid phosphatase
US3119740A (en) Process for preparing purified follicle stimulating hormone
Moss Separation of Serum 5′-Nucleotidase and Non-specific Alkaline Phosphatase Activities
SU1219645A1 (en) Method of cleaning proteolytic complex
SU805631A1 (en) Method for preparing form of terminal desoxynucleotidyl transferase from calf thymus
US3994782A (en) Methods for extracting and purifying kallidinogenase
FR2047889A1 (en) Fibrinolytic enzyme separation from mould - fungus cultures
US4038141A (en) Methods for extracting and purifying kallidinogenase
Ôtakara Studies on the Chitinolytic Enzymes of Black-koji Mold Part V. Participation of Two Different Enzymes in the Decomposition of Glycol Chitin to Constituent Aminosugar
SU542762A1 (en) Method for isolating invertase from yeast
Saldeen et al. Effect of pulmonary blood flow on the elimination of fibrin from the lungs